IMPAX LABORATORIES INC Contracts & Agreements

Second Supplemental Indenture (Filed With SEC on May 7, 2018)

Stock and Asset Purchase Agreement, dated as of December 19, 2017, by and between the Company and Bora Pharmaceuticals Co., Ltd (Filed With SEC on March 1, 2018)

Master Supply Agreement, dated as of December 19, 2017, between the Company, Bora Pharmaceuticals Co., Ltd. and Impax Laboratories (Taiwan), Inc (Filed With SEC on March 1, 2018)

Separation Agreement dated as of January 8, 2018 between Michael J. Nestor and Impax Laboratories, Inc (Filed With SEC on January 9, 2018)

Amendment No. 2 to the Business Combination Agreement, dated December 16, 2017 (Filed With SEC on December 20, 2017)

Employment Agreement dated as of December 16, 2017 by and among Amneal Pharmaceuticals LLC, Atlas Holdings, Inc. and Robert A. Stewart (Filed With SEC on December 20, 2017)

Memorandum of Understanding dated as of December 16, 2017 by and among Amneal Pharmaceuticals LLC, Paul M. Bisaro, Impax Laboratories, Inc. and Atlas Holdings, Inc (Filed With SEC on December 20, 2017)

Supplemental Indenture, dated November 6, 2017, by and between Impax Laboratories, Inc. and Wilmington Trust, National Association (Filed With SEC on November 7, 2017)

Form of Stock Option Agreement under the Companys Fourth Amended and Restated 2002 Equity Incentive Plan (Filed With SEC on August 9, 2017)

Form of Restricted Stock (Stock Bonus) Award Agreement under the Companys Fourth Amended and Restated 2002 Equity Incentive Plan (Filed With SEC on August 9, 2017)

AMENDMENT NO. 1 TO CREDIT AGREEMENT (Filed With SEC on May 10, 2017)

EMPLOYMENT AGREEMENT (Filed With SEC on May 10, 2017)

IMPAX LABORATORIES, INC. STOCK OPTION AGREEMENT (Filed With SEC on May 10, 2017)

(Signature Page Follows) (Filed With SEC on March 1, 2017)

General Release and Waiver (Filed With SEC on March 1, 2017)

FIRST AMENDMENT TO DISTRIBUTION, LICENSE, DEVELOPMENT AND SUPPLY AGREEMENT (Filed With SEC on August 9, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on August 9, 2016)

IMPAX LABORATORIES, INC. AND WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of June 30, 2015 2.00% Convertible Senior Notes due 2022 TABLE OF CONTENTS (Filed With SEC on June 30, 2015)

Exhibit 10.2[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.Confidential treatment has been requested... (Filed With SEC on May 3, 2013)

[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.Confidential treatment has been requested with respect... (Filed With SEC on February 26, 2013)

SECOND AMENDMENT TO CREDIT AGREEMENT (Filed With SEC on January 10, 2013)

EMPLOYMENT AGREEMENT (Filed With SEC on December 13, 2012)

General Release and Waiver (Filed With SEC on July 18, 2012)

DISTRIBUTION, LICENSE, DEVELOPMENT AND SUPPLYAGREEMENT between ASTRAZENECA UK LIMITED and Impax LABORATORIES, INC. Dated as of January 31, 2012 TABLE OF CONTENTS (Filed With SEC on April 2, 2012)

PROPOSED TERMSOF EMPLOYMENT (REVISED) (Filed With SEC on February 28, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on February 28, 2012)

AMENDMENT TO LICENSE AND DISTRIBUTION AGREEMENT (Filed With SEC on February 28, 2012)

FIRST AMENDMENT TO JOINT DEVELOPMENT AGREEMENT DATED NOVEMBER 26, 2008 (Filed With SEC on February 28, 2012)

FIRST AMENDMENT OF THE LICENSE, DEVELOPMENT AND COMMERCIALIZATIONAGREEMENT (Filed With SEC on February 28, 2012)

DISTRIBUTION, LICENSE, DEVELOPMENT AND SUPPLYAGREEMENT between ASTRAZENECA UK LIMITED and Impax LABORATORIES, INC. Dated as of January 31, 2012 TABLE OF CONTENTS (Filed With SEC on February 6, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on November 9, 2011)

OFFER OF EMPLOYMENT (REVISED) (Filed With SEC on November 3, 2011)

[Letterhead of Impax Laboratories, Inc.] (Filed With SEC on July 11, 2011)

62 ANDAs approved by the Food and Drug Administration (FDA), which include generic versions of brand name pharmaceuticals such as Brethine, Florinef, Minocin, Claritin-D 12-hour,... (Filed With SEC on February 25, 2011)

as adjusted (Filed With SEC on November 4, 2009)

as adjusted (Filed With SEC on August 5, 2009)

PROMOTIONAL SERVICES AGREEMENT (Filed With SEC on July 2, 2009)

as adjusted (Filed With SEC on May 7, 2009)

SECOND AMENDMENT TO AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (Filed With SEC on March 12, 2009)

AMENDMENT NO. 1 TO IMPAX LABORATORIES, INC. 1995 STOCK INCENTIVE PLAN (Filed With SEC on March 12, 2009)

AMENDMENT NO. 2 TO IMPAX LABORATORIES, INC. 1995 STOCK INCENTIVE PLAN (Filed With SEC on March 12, 2009)

1999 Equity Incentive Plan (Filed With SEC on March 12, 2009)

IMPAX LABORATORIES, INC. STOCK OPTION GRANT Optionee Name: Address: Total Option Shares: Exercise Price Per Share: Date of Grant: Expiration Date: Type of Option: [ ] Incentive... (Filed With SEC on March 12, 2009)

IMPAX LABORATORIES, INC. AMENDED AND RESTATED 2002 EQUITY INCENTIVE PLAN (Filed With SEC on March 12, 2009)

IMPAX LABORATORIES, INC. STOCK OPTION GRANT Optionee Name: {FirstName} {LastName} Address: Total Option Shares: {Grant} Exercise Price Per Share: Date of Grant: Expiration Date:... (Filed With SEC on March 12, 2009)

IMPAX LABORATORIES, INC. (Filed With SEC on March 12, 2009)

[LETTERHEAD OF IMPAX LABORATORIES, INC.] (Filed With SEC on March 12, 2009)

IMPAX Laboratories (Taiwan), Inc. IMPAX Jhunan Plant Project MEP Construction Package Construction Work Agreement (Filed With SEC on March 12, 2009)

[Translation] (Filed With SEC on March 12, 2009)

Exhibit 4.1-Rights Agreement (Filed With SEC on January 22, 2009)

EMPLOYMENT AGREEMENT (Filed With SEC on September 8, 2006)

Exhibit 10.1 CONSULTING/SEPARATION AGREEMENT AND FULL MUTUAL RELEASE (Filed With SEC on August 18, 2006)

Category

Industry

Companies

Contracts

IMPAX LABORATORIES INC Contracts & Agreements